ORMP
$2.56
Oramed Pharma
$.07
2.81%
ORMP
Earnings Whisper ®
N/A
4th Quarter August 2020
Consensus:  ($0.15)
Revenue:  $0.69 Mil
Wednesday
Nov 25
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when ORMP reports earnings?
Beat
Meet
Miss

Where is ORMP's stock price going from here?
Up
Flat
Down
Stock chart of ORMP
Analysts
Summary of analysts' recommendations for ORMP
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.